| Hot-Stocks Übersicht |
| LANXESS Aktie | +8,33% |
| SUSS MICROTEC Aktie | +8,24% |
| VINCORION Aktie | +8,01% |
| VESTAS Aktie | +5,56% |
| EVONIK Aktie | +5,46% |
| JDC GROUP Aktie | +4,81% |
| MUTARES Aktie | +3,70% |
| NOVO NORDISK Aktie | +3,21% |
| TEVA Aktie | +2,91% |
| RENK Aktie | +2,38% |
| ELMOS Aktie | +2,35% |
| EQUINOR Aktie | +2,34% |
| RHEINMETALL Aktie | +2,16% |
| HOLCIM Aktie | -2,07% |
| NEMETSCHEK Aktie | -2,19% |
| SATURN OIL Aktie | -2,22% |
| SONY Aktie | -2,42% |
| IDORSIA Aktie | -2,53% |
| COREWEAVE Aktie | -2,82% |
| SPACEX Aktie | -2,86% |
| TUI Aktie | -3,18% |
| UMICORE Aktie | -3,71% |
| FREQUENTIS Aktie | -3,84% |
| NEWMONT Aktie | -3,97% |
| SOFTBANK Aktie | -4,08% |
| BHP GROUP Aktie | -4,24% |
| VOLKSWAGEN VZO Aktie | -4,66% |
| SAMSUNG VZ Aktie | -4,89% |
| LUDWIG BECK Aktie | -8,76% |
| ALAMOS GOLD Aktie | -19,07% |
| NOVOCURE LTD |
| Großbritannien |
| Gesundheit |
| JE00BYSS4X48 / A140ML |
| 038 (Frankfurt) / NVCR (NASDAQ) |
| FRA:038, ETR:038, 038:GR, NASDAQ:NVCR |
| - |
| https://www.novocure.com/ |
|
Novocure Ltd. is a global oncology company that develops and commercializes Tumor Treating Fields (TTFields), an innovative, non-invasive cancer therapy using alternating electric fields tuned to specific frequencies to disrupt cancer cell division w..
>Volltext.. |
| 1803.91 Mio. EUR |
| 1624.21 Mio. EUR |
| 588.46 Mio. EUR |
| -146.51 Mio. EUR |
| -150.99 Mio. EUR |
| -1.34 EUR |
| 205 Mio. EUR |
| 84.92 Mio. EUR |
| -23.46 Mio. EUR |
| 2.03 |
| 1.57% |
| 1.31% |
| - |
| - |
| - |
| NOVOCURE |
| 20.06.26 |
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
